Stocks
Vanda Pharmaceuticals (VNDA) Revenue US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Revenue, bln rub | ? | 227.2 | 248.2 | 268.7 | 254.4 | 192.6 | 190.9 | ||
| Changes by years, y/y, % | +18% | +9% | +8% | -5% | -24% | 0.0% | |||
Vanda Pharmaceuticals. Revenue US GAAP, bln rub
Vanda Pharmaceuticals. Revenue US GAAP, changes, %
Vanda Pharmaceuticals. Revenue US GAAP, sum by quarters, bln rub
Vanda Pharmaceuticals (VNDA) Revenue US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Revenue, bln rub | ? | 38.8 | 45.3 | 47.5 | 50.5 | 47.7 | 190.9 | |
| Changes by years, y/y, % | -41% | -30% | -24% | +10% | +23% | |||
| Changes by quarters, q/q, % | -16% | +17% | +5% | +6% | -6% | |||
